Chronic Kidney Disease-Mineral and Bone Disorder, Chronic Kidney Failure, Dialysis, Hemodialysis
Conditions
Brief summary
This study was conducted with 167 dialysis patients at Erciyes University Faculty of Medicine, Department of Internal Medicine, Department of Nephrology, and Dialysis Unit, with the approval of the Ethics Committee of Erciyes University Medical Faculty (date: 25.09.2019, no: 2019/673). Patients aged ≥18 years, undergoing dialysis treatment, and having available data on serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium levels within the last six months were included in the study.
Interventions
Hemodialysis or peritoneal Dialysis
Sponsors
Study design
Eligibility
Inclusion criteria
* Age ≥ 18 years, * Diagnosed with chronic kidney disease (CKD) and undergoing dialysis treatment (hemodialysis or peritoneal dialysis) * Availability of laboratory results within the last 6 months: serum calcium, phosphorus, parathormone, albumin, hemoglobin, blood urea nitrogen (BUN), creatinine, and dialysate calcium * Patient consent to participate
Exclusion criteria
* Age \< 18 years * Patients not on dialysis treatment * Missing or incomplete laboratory data * History of malignancy, acute infection, or other systemic diseases interfering with mineral and bone metabolism * Patients who did not provide consent or could not complete the questionnaire
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Blood values | At the enrollment | Serum levels of calcium, phosphorus, parathyroid hormone, albumin, hemoglobin, BUN, creatinine, and dialysate calcium |
Countries
Turkey (Türkiye)